William Edward Evans
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 267
-
- Childhood Cancer Survivors' Quality of Life 103
- Pharmaceutical studies and practices 37
- Co-authors
- Mary V. Relling (168 shared papers)Ching‐Hon Pui (124 shared papers)Howard L. McLeod (10 shared papers)Eugene Y. Krynetski (29 shared papers)Gaston K. Rivera (43 shared papers)John T. Sandlund (38 shared papers)Raul Correa Ribeiro (37 shared papers)James R. Downing (23 shared papers)
- Journals
- Blood (72 papers)Journal of Clinical Oncology (37 papers)Clinical Pharmacology & Therapeutics (29 papers)Nature Genetics (15 papers)New England Journal of Medicine (11 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
William Edward Evans
465 papers receiving 47.6k citations
William Edward Evans's Hit Papers
Peers
Comparison fields: 5 of 205
- Hematology 11.3k
- Public Health, Environmental and Occupational Health 23.4k
- Pharmacology 6.5k
- Pediatrics, Perinatology and Child Health 12.7k
- Oncology 8.0k
Countries citing papers authored by William Edward Evans
This map shows the geographic impact of William Edward Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Edward Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Edward Evans more than expected).
Fields of papers citing papers by William Edward Evans
This network shows the impact of papers produced by William Edward Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Edward Evans. The network helps show where William Edward Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside William Edward Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 480 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics Hit paper breakdown → | 1999 | 1983 |
| 2 | Treatment of Acute Lymphoblastic Leukemia Hit paper breakdown → | 2006 | 1597 |
| 3 | Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling Hit paper breakdown → | 2002 | 1560 |
| 4 | Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia Hit paper breakdown → | 2007 | 1480 |
| 5 | Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects Hit paper breakdown → | 2003 | 1402 |
| 6 | The genetic basis of early T-cell precursor acute lymphoblastic leukaemia Hit paper breakdown → | 2012 | 1318 |
| 7 | Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia Hit paper breakdown → | 2014 | 1116 |
| 8 | Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation Hit paper breakdown → | 2009 | 1002 |
| 9 | A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study Hit paper breakdown → | 2009 | 766 |
| 10 | Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration Hit paper breakdown → | 2015 | 762 |
| 11 | Acute Lymphoblastic Leukemia Hit paper breakdown → | 1998 | 721 |
| 12 | Applied pharmacokinetics : principles of therapeutic drug monitoring Hit paper breakdown → | 1992 | 699 |
| 13 | Pharmacogenomics in the clinic Hit paper breakdown → | 2015 | 664 |
| 14 | Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia Hit paper breakdown → | 1991 | 624 |
| 15 | Moving towards individualized medicine with pharmacogenomics Hit paper breakdown → | 2004 | 582 |
| 16 | 2005 | 554 | |
| 17 | 2004 | 505 | |
| 18 | Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT 15 Genotypes: 2018 Update Hit paper breakdown → | 2018 | 499 |
| 19 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing Hit paper breakdown → | 2011 | 473 |
| 20 | PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Hit paper breakdown → | 2019 | 450 |
About William Edward Evans
William Edward Evans is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Hematology, Oncology and Pharmacology, having authored 480 papers that have together received 49.9k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (267 papers), Childhood Cancer Survivors' Quality of Life (103 papers), Acute Myeloid Leukemia Research (53 papers), Pharmacogenetics and Drug Metabolism (38 papers), Pharmaceutical studies and practices (37 papers), Cancer therapeutics and mechanisms (33 papers), Cancer Treatment and Pharmacology (26 papers) and Chronic Myeloid Leukemia Treatments (25 papers). The work is most often cited by research in Hematology (11.3k citations), Public Health, Environmental and Occupational Health (23.4k citations), Pharmacology (6.5k citations), Pediatrics, Perinatology and Child Health (12.7k citations) and Oncology (8.0k citations). William Edward Evans has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Mary V. Relling, Ching‐Hon Pui, Howard L. McLeod, Eugene Y. Krynetski, Gaston K. Rivera, John T. Sandlund, Raul Correa Ribeiro, James R. Downing, Cheng Cheng and Wenjian Yang. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, Nature Genetics and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.